This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

John R. Hughes, MD

JAMA. 1988;259(19):2901-2902.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Pharmacologic treatment of smoking is not a new idea.¹ However, the search for effective pharmacologic treatments for smoking has increased dramatically in the last ten years due to the realization that smoking is a dependence disorder²; that behavioral strategies are not having a large effect on the prevalence of smoking³; and that nicotine dependence is becoming more prevalent in smokers due to a selection process.⁴ This latter process is occurring because smokers who are quitting appear to be smokers who are less dependent on nicotine. Thus, if this trend continues, in ten to 20 years the population of smokers will be almost exclusively smokers who are highly dependent on nicotine.

See also page 2863.

Nicotine gum was introduced in 1984 as the first proven pharmacologic aid for smoking cessation.⁵ Encouraged by this success, other nicotine replacement therapies, eg, nicotine patch⁶ and nicotine nasal spray, . . . [Full Text PDF of this Article]

Author Affiliations
University of Vermont Burlington

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?